What type of study is this?

This is a Cohort Study study (also classified as: Validation Study).

November 30, 2025Frontiers in OncologyOpen Access

Prognostic assessment of diffuse large B-cell lymphoma using ultrasound imaging nomogram and PET/CT indicators

View Full Paper

Ask AI

Bookmark

Combination of ultrasound imaging and PET/CT indicators improves prognostic accuracy in non-Hodgkin lymphoma, enhancing personalized treatment.
The ACR-Rad nomogram predicted progression-free survival more accurately than the International Prognostic Index alone.
Multivariate Cox regression analysis identified key independent risk factors for patient outcomes in diffuse large B-cell lymphoma.
New prognostic models may support improved clinical decision-making for patients with aggressive lymphoma.

No takes yet. Share an insight, caveat, or question.

Retrospective analysis improved risk stratification for non-Hodgkin lymphoma, highlighting the role of progression-free survival.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark